-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Vistagen Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q2 2010 to Q2 2024.
- Vistagen Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending June 30, 2024 was -$10.9M, a 37.7% decline year-over-year.
- Vistagen Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$25.8M, a 48.1% increase from 2022.
- Vistagen Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$49.7M, a 9.85% decline from 2021.
- Vistagen Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$45.3M, a 275% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)